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Abstract
Background: Natural product is one of the most important sources of drugs used in pharmaceutical therapeutics.
Artemisia capillaris has been traditionally used as a hepatoprotective and anti-inflammatory agent. In this study, we
extracted an ethanol fraction (LAC117) from the dried leaves of Artemisia capillaris and identified its anticancer
activity and mechanism of action against hepatocellular carcinoma (HCC).
Methods: Anti-proliferative effect of LAC117 was evaluated by MTT assay and BrdU assay. The apoptotic effect of LAC117
on the expression of cleaved PARP and cleaved caspase-3 was evaluated by Western blot and immunohistochemistry
from in vivo mouse xenograft, respectively.
Results: We found that LAC117 strongly suppressed the growth and proliferation of human HCC cell lines (HepG2 and
Huh7). Induction of apoptosis was evidenced by the increases of cleaved caspase-3 and PARP as well as TUNEL-positive
cells. Additionally, the pro-apoptotic effect of LAC117 was observed by a decrease in the expression of the XIAP and an
increase in cytochrome c releases via mitochondrial membrane potential. Moreover, it significantly inhibited PI3K/AKT
pathway in HCC in vivo and in vitro. LAC117 suppressed tumor growth in an ex vivo model as well as in vivo mouse
xenograft by inducing apoptosis and inhibiting tumor cell proliferation.
Conclusions: The present study highlights that LAC117 could not only efficiently induce apoptosis, but also inhibit the
growth of human HCC cells by blocking the PI3K/AKT signaling pathway, suggesting that LAC117 would be a potentially
useful drug candidate against HCC.
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Background
Hepatocellular carcinoma (HCC) is the sixth most com-
monly diagnosed cancer and the third leading cause of
cancer-related deaths in the world [1]. Although conven-
tional anticancer drugs such as sorafenib and doxorubicin
have been used for the treatment of HCC, their tox-
icity and tolerance prevent long-term use [2]. Re-
cently, natural anticancer drugs have been considered as
alternative medicines because of their safety associated
with long-term exposure [3]. Traditional herbal medicines
have been widely used for HCC prevention and treatment
because of their multi-targeted and coordinated interven-
tion effects, and their significant anti-cancer activity has
been identified [4, 5]. Natural plants, including Pulsatilla
koreana and Petasites japonicus have already been shown
to suppress the growth of HCC cells through modulation
of cell proliferation, differentiation, apoptosis, angiogen-
esis as well as several signal transduction pathways [5, 6].
The efficacy of several natural products in cancer has been
tested by clinical intervention trials that support the po-
tential utility of these agents in the cancer prevention,
treatment, and management regimens [7].
Artemisia species have been used as food additives and
traditional herbal medicines, particularly in various
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diseases such as cancer, inflammation, malaria, hepatitis,
and microbial infections [8–10]. Among Artemisia species,
Artemisia capillaris (AC) showed the anti-inflammatory ef-
fects in atopic dermatitis, chronic hepatitis B virus infec-
tion, and liver cirrhosis [11, 12]. Also aqueous extract of
AC has been shown to inhibit interleukin-1 receptor
(IL-1R)- and tumor necrosis factor receptor (TNF-α)-
induced cytotoxicity and ethanol-induced apoptosis of liver
cells [13]. In addition, AC inhibited inflammatory response
through preventing NF-kappa B activation in HCC cells
[14]. In addition to the anti-inflammatory effects of AC in
cancer, its anticancer capacity has recently been reported
in different type cancers. Indeed, AC inhibited cell growth
and induced apoptosis in breast cancer and leukemia [15,
16]. Moreover, the major constituents of AC such as capil-
lin and scoparone exhibit anti-cancer effects in breast,
prostate, lung, and liver cancers [17–19]. However, there
have been no previous studies evaluating the anti-cancer
effect of AC leaves in vitro and in vivo models of HCC. In
this study, we newly extracted an ethanol fraction
(LAC117) from the dried leaves of AC and investigated its
anticancer activity and mechanism of action against HCC.
Methods
Chemicals and antibodies
Primary antibodies against cleaved PARP (cat.n.9541),
cleaved caspase-3 (cat.n.9661), XIAP (cat.n.2042), p-AKT
(cat.n.4060), p-GSK3β (cat.n.5558), p-mTOR (cat.n.2971),
and β-actin (cat.n.4970) were purchased from Cell Signal-
ing Technology (Danvers, MA), PCNA (cat.n.ab29) from
Abcam (Cambridge, MA), and cytochrome c (cat.n.13156)
from Santa Cruz Biotechnology (Dallas, CA).
Sample preparation of the LAC117 fraction
The dried leaves of Artemisia capillaris were purchased
from Jung Do Herbal Drug Co. (Gyeonggi Province,
Korea) and the voucher specimen (DBH16011101) was
deposited in the Herb Resource Bank of Traditional
Korean Medicine (http://herb-bank.com), Kyung Hee
University (Seoul, Korea). The dried material (5 g)
was extracted with 50 mL of 70% ethanol for 24 h at room
temperature. Next, the extract was filtered, concentrated
on a rotary vacuum evaporator, and completely freeze-
dried (yield: 7.12%). The powder was stored at 4 °C.
Chromatographic conditions of HPLC-MS analysis
An Agilent 1100 series HPLC system (Agilent Corp.,
Santa Clara, CA) was used to acquire chromatograms.
All the chromatographic analysis was performed on a
Phenomenex Kinetex C18 column (100 mm × 4.6 mm
i.d. 2.6 μm). The mobile phase was composed of 0.1%
formic acid in distilled water and 0.1% formic acid in
methanol. The conditions of solvent gradient elution were
30% in 0–2 min, 30–90% in 2–12 min, 90% in 12–22 min,
Fig. 1 HPLC-MS chromatogram fingerprinting of LAC117
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90–30% in 22–22.1 min, 30% in 22.1–30 min, at a flow
rate of 0.5 mL/min. The column temperature was main-
tained at 40 °C, and all the injection volumes of sample
solutions were fixed at 2 μL. The eluent was directed to
an ESI-LTQ-XL-Linear Ion Trap (Thermo Scientific) mass
spectrometer and the data was acquired in full-scan and
positive mode with mass range from 100 to 800 m/z.
Cell culture
HCC cells (Huh7 and HepG2) were purchased from
JCRB (Shinjuku, Japan) and American Type Culture
Collection (Manassas, VA), respectively. Huh7 cells
were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM), and HepG2 cells were cultured in Minimum
Essential Media Eagle (MEM) supplemented with 10%
heat-inactivated fetal bovine serum (FBS, cat.n. 26,140–
079) and 1% penicillin/streptomycin. FBS and all other
reagents used for cell culture were purchased from
Invitrogen (Carlsbad, CA). The cultures were maintained
at 37 °C in an incubator with a controlled humidified
atmosphere composed of 95% air and 5% CO2.
Measurement of cell viability
Cell viability was determined using an MTT assay. In
brief, cells were seeded at a density of 4 × 103 cells/well
in 96-well plates, followed by overnight incubation. On
the following day, the media were removed, and the cells
were treated with either vehicle as a negative control or
various concentrations of LAC117 (1–100 μg/mL) and
incubated for 72 h. After incubation of respective time,
10% of an MTT solution (2 mg/mL, Sigma, cat.n.M2128)
was added to each well, and the cells were incubated for
another 4 h at 37 °C. The formazan crystals were dissolved
in DMSO (100 μL/well, Sigma, cat.n.D2160) with constant
shaking for 5 min. The absorbance of the plate was then
read with a microplate reader at 540 nm. Three replicate
wells were evaluated for each analysis.
Measurement of cell proliferation
To measure the cell proliferation activity of LAC117 in
Huh7 and HepG2 cells, 8 × 103 cells were plated per well
onto 96-well plates. Following overnight culture,
LAC117 was added at specified concentrations. After
24 h of incubation, cell proliferation was measured with
a
b
Fig. 2 Effect of LAC117 on the growth and proliferation of HCC cells. a Huh7, HepG2, and HL-7702 cells were treated with LAC117 at the indicated
concentration for 72 h, and then MTT assays were performed. b BrdU assay was performed to identify proliferation of HCC cells. Cells were treated with
10, 50, and 100 μg/mL of LAC117 for 24 h. Data are represented as means ± SEM of triplicates
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a BrdU assay kit (Cell Signaling, cat.n.6813) per the
manufacturer’s instructions. Plates were read at 450 nm
by using a spectrometer.
Western blotting
The cells were washed with DPBS before being lysed in
a lysis buffer containing protease and phosphatase inhib-
itors. Equal amounts of proteins were separated using 8,
10 or 12% sodium dodecyl sulfate (SDS)–polyacrylamide
gel electrophoresis and transferred onto polyvinylidene
fluoride (PVDF) membranes. Protein transfer was
confirmed using a Ponceau S staining solution (Sigma,
cat.n.P7170). The blots were then immunostained with
the appropriate primary antibodies (1:1000) followed by
appropriate secondary antibodies (1:5000) conjugated to
horseradish peroxidase. The primary antibodies specific to
the interested proteins were used and detected manually
using an X-Ray film by enhanced chemiluminescence
(Amersham Biosciences, Piscataway, NJ).
TUNEL staining
Huh-7 and HepG2 cells were plated onto chamber slides
at a density of 5 × 104 cells per chamber. At 24 h post-
incubation, cells were treated with LAC117 (100 μg/mL)
at 37 °C for 24 h. Coverslips with adherent cells were
fixed in 4% paraformaldehyde (PFA) for 15 min at room
temperature, and then rinsed in distilled PBS and incu-
bated with equilibration for 1 min. TUNEL assay was
subsequently performed by using a TUNEL kit ApopTag®
Peroxidase In Situ Apoptosis Detection Kit (Merck Milli-
pore, Temecula, CA. cat.n.S7100) in accordance with the
manufacturer’s instructions. Huh7 and HepG2 cells were
plated on 18-mm cover glasses for 24 h and treated with
LAC117 (100 μg/mL). Apoptotic cells were visually identi-
fied in 10 randomly selected fields and photographed at a
magnification of × 200. Apoptotic cells were counted to
calculate the percentage of TUNEL-positive cells.
Detection of cytochrome c location
HepG2 and Huh7 cells were plated on 18-mm cover
glasses for 24 h and then treated with LAC117
(100 μg/mL). A mitochondrion-specific dye (MitoTracker
Red FM: Molecular Probes Inc., Eugene, OR, cat.n.
M22426) was added and incubated for another 30 min.
The media were removed, and the cells were washed with
PBS and fixed with an acetone: methanol solution for
5 min at − 20 °C. The fixed cells were washed with
PBS for several times and incubated with cytochrome
a b
c
Fig. 3 Effect of LAC117 on mitochondria-mediated apoptosis in HCC cells. a Huh7 and HepG2 cells were treated with LAC117 (100 μg/mL) for 6 h,
and then stained with Mitotracker (green) and cytochrome c (red). Localization of cytochrome c in the cytosol was analyzed by confocal fluorescent
microscopy at × 200 magnification. b Before performing TUNEL assay, HepG2 and Huh7 cells were treated with LAC117 (100 μg/mL) for 24 h. The
results were observed by microscopy at × 200 magnification. c The expression of cleaved caspase-3, PARP, and XIAP was determined by Western blotting
in cells treated with LAC117 (100 μg/mL) for 24 h. Data are represented as mean ± SEM of triplicates (*P< 0.05 and **P< 0.01vs Con)
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c antibody (Santa Cruz Biotechnologies, cat.n.13156)
overnight at 4 °C. Subsequently, after washing with
PBS several times, the cells were incubated with a
mouse fluorescenct-labeled secondary antibody (1:100,
Vector Laboratories, Burlingame, CA, cat.n.TI-2000)
for 1 h at room temperature. The cells were stained
with DAPI to visualize the nuclei. Finally, the cells
were covered with a fluorescent mounting solution
(Dako, Carpinteria, CA, cat.n.REF3023) before viewing
with a confocal laser scanning microscope (Olympus,
Tokyo, Japan).
Tumor xenograft study
All animal experiments were performed in accordance
with the guidelines of the INHA Institutional Animal
Care and Use Committee (INHA IACUC) of the Medical
School of Inha University (approval ID: INHA 150915–
379-1). The cells (HepG2) were harvested and mixed in
PBS. Six-week-old male BALB/c nu/nu mice (Orient
Bio, Seoul, Korea) were inoculated with 1 × 107 cells in
the flank. When the tumor size reached approximately
50–100 mm3, mice were randomly divided into 2 groups
(4 mice per group). Next, LAC117 (100 mg/kg) or vehicle
(1% Tween 80) was administrated intraperitoneally once
daily for 15 days. At the end of the 15 days treatment
period, the animals were anaesthetized with mixture of
ketamine (100 mg/kg) and xylazine (2%, 20 mg/kg).
Tumor size was measured every 2 days, and it was
calculated using the following formula: 0.5 × length ×
width2.
Ex vivo organotypic spheroid culture
Male BALB/c nu/nu mice (4 weeks old, weighing 18–20 g)
were obtained from Orient Bio. Animal Inc. (Seoul,
Republic of Korea). The animals were fed standard
rat chow and tap water ad libitum, and were main-
tained under a 12 h dark/light cycle at 21 °C. After
one week of adaptation, Huh7 (8 × 106 cells/mice) was
inoculated into the right flanks of mice. When the
tumor size reached approximately 300–500 mm3, they
were surgically removed (n = 5). A 2-mm diameter section
was excised and explanted on 2% agarose-coated 24 well
plates with culture medium at 37 °C. After overnight incu-
bation, the tumor spheroids were subjected to treatment
with or without LAC117 (100 μg/mL) for 7 days. For IHC
analysis, tissues were immediately fixed in 4% PFA
overnight and paraffin-embedded slides were prepared
for further analysis.
Immunohistochemistry
Immunohistochemical staining of fixed paraffin-embedded
specimens was performed using 8-μm-thick sections. Heat-
induced epitope retrieval (HIER) was performed in a citrate
buffer (pH 6.0) for 5 min before peroxidase quenching with
Fig. 4 Effect of LAC117 on PI3K/AKT signaling pathway in HCC cells. To investigate the effect of LAC117 on PI3K/AKT signaling pathway, HepG2
and Huh7 cells were treated with 100 μg/mL of LAC117 for 1 h, and expression levels of p-AKT, p-mTOR, p-GSK3β, and β-actin were determined
by Western blotting analysis. Data are represented as the mean ± SEM from triplicate experiments (*P < 0.05 and **P < 0.01vs Con)
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3% hydrogen peroxide (H2O2) in PBS for 10 min. The
tissue sections were washed with PBS and blocked with
normal goat or horse serum for 1 h and incubated at
4 °C overnight in 1:50 dilutions of primary antibodies
against cleaved caspase-3, PCNA, p-AKT, and p-mTOR.
The sections were then incubated with biotinylated
secondary antibodies (1:100) for 1 h. The sections were
visualized with an avidin-biotin peroxidase complex
solution using an ABC kit (Vector Laboratories, cat.n.PK-
6101), washed in PBS and developed with a diaminobenzi-
dine tetrahydrochloride (DAB) substrate for 5 min, and
then counterstained with hematoxylin. At least 3 randomly
selected fields for each section were examined at x 200
magnification and analyzed.
Statistical analysis
Data were presented as mean ± SEM, and were ana-
lyzed by an ANOVA and unpaired Student’s t-test. A
P-value of 0.05 or less was indicated statistical signifi-
cant. Comparisons of results were performed using a
Student’s t-test.
Results
HPLC-MS analysis of LAC117
The protective effects of the AC against cancer have
previously been reported (14). AC contains potent com-
pounds as anti-inflammatory or anti-cancer compo-
nents such as chlorogenic acid, esculetin, scopoletin,
isochlorogenic acid, scoparone, hyperin, isorhamnetin-
1,6-diglucoside, artepillin, and capillin, which are
marker components of AC. Therefore, we identified
whether LAC117 isolated from leaves of AC contains
these components using HPLC-MS analysis. The chro-
matogram revealed the strong presence of the scoparone
(RT = 9.29 min, 207 m/z; peak 4), chlorogenic acid
(RT = 3.41 min, 355 m/z; peak 1), isorhamnetin-1,6-
diglucoside (RT = 10.42 min, 625 m/z; peak 6), and
hyperin (RT = 9.38 min, 465 m/z; peak 5, Fig. 1). The
molecules responsible for these signals were identified
by comparing them to the spectra and retention time
of known standard compounds.
LAC117 inhibits the proliferation of HCC cells
To examine the effects of LAC117 on cell growth and
viability, we performed the MTTassay using two HCC cell
lines (HepG2 and Huh7). The cells were exposed to the
indicated concentrations of LAC117 (1 to 100 μg/mL) for
72 h. LAC117 reduced cell viability of both HepG2 and
Huh7 cells in a dose-dependent manner (Fig. 2a). In
particular, LAC117 treatment inhibited cell growth by
60~ 90% at dose of 50 μg/mL depending on the cell
type. To further evaluate this result, we determined
cell proliferation by using the BrdU cell proliferation
assay (Fig. 2b). In agreement with the MTT assay,
LAC117 dose-dependently inhibited the proliferation of
HCC cells. In the both studies, we found that Huh7 cells
were more sensitive to LAC117 than HepG2 cells.
LAC117 induces mitochondria-mediated apoptosis of
HCC cells
During apoptosis, mitochondrial membrane potential
regulates matrix configuration and the rapid release of
cytochrome c from the mitochondrial intermembrane
space into the cytosol. Therefore, we investigated whether
LAC117 increases the release of cytochrome c through loss
of mitochondria membrane potential. For this experiment,
HepG2 and Huh7 cells were treated with LAC117
(100 μg/mL) for 6 h and then observed cytochrome c
release into the cytosol by double staining with
a
b
Fig. 5 Effect on HCC tumor ex vivo models. a Huh7 xenograft tumors
from Balb/c nude mice (n = 5) were harvested and cut into small
pieces of ~ 2 mm, and each piece was maintained in culture
media. Tumor spheroids cultured from the pieces were treated
with LAC117 (100 μg/mL) for 7 days. b Tumor spheroids were
excised and processed for immunostaining for PCNA, cleaved
caspase-3, and H&E staining. The results were observed by microscopy
at ;× 400 magnification
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Mitotracker (green) and antibody against cytochrome c
(red) in HCC cells. In this study, we observed that LAC117
significantly increased cytochrome c release which triggers
the apoptotic process through caspase activation (Fig. 3a).
We also investigated whether LAC117 could increase
cleaved caspases 3/PARP, leading to apoptosis in HCC
cells. When treated with LAC117 (100 μg/mL) for 24 h,
the cells showed morphological features of apoptotic cells,
such as DNA fragmentation by TUNEL staining. Also, the
percentages of TUNEL-positive cells were increased in the
LAC117-treated groups (Fig. 3b). We further found in
western blotting study that treatment with LAC117 signifi-
cantly increased the expression of apoptotic proteins
(cleaved PARP and cleaved caspase-3), whereas the
expression of anti-apoptotic protein (XIAP) was decreased
in both cell lines, compared with control (Fig. 3c).
These results indicate that LAC117 could induce
mitochondria-mediated apoptosis in HCC cells.
LAC117 inhibits PI3K/AKT pathway
Deregulated PI3K/AKT/mTOR signaling pathways are
commonly found in HCC [20]. To understand the mech-
anism underlying the enhanced ant-cancer effect of
LAC117, we investigated the inhibition of the PI3K/AKT
signaling pathway in Huh7 and HepG2 cells after
LAC117 (100 μg/mL) treatment for 1 h. LAC117 was
observed to decrease the phosphorylation of AKT,
mTOR, and GSK3β in Huh7 cells (Fig. 4).
LAC117 increases apoptosis and inhibits cell proliferation
in ex vivo tumor organotypic spheroids
To further determine the apoptotic effect of LAC117, an
ex vivo organotypic spheroid culture was established
using xenograft-derived tumors in the Balb/c nude mice
(Fig. 5a). As observed by H&E staining, apoptotic cells
were significantly increased in the LAC117-treated
group compared to that of the control group (Fig. 5b).
Moreover, LAC117 treatment decreased the number of
proliferating cells (PCNA-positive cells), but increased
the number of apoptotic cells (cleaved caspase-3 positive
cells, Fig. 5b). Taken together, our results show that
LAC117 exhibit potent anti-cancer activity by inhibiting
cell proliferation and inducing apoptosis.
LAC117 inhibits tumor growth in vivo
To further assess whether LAC117 suppresses tumor
growth in vivo, HCC xenograft models were used in
Balb/c nude mice. After inoculation with HepG2 cells,
mice were injected intraperitoneally with 100 mg/kg
LAC117 for 15 days. As shown in Figs. 5c and 6a,
c d
ba
Fig. 6 Tumor growth inhibition of LAC117 in HepG2 HCC xenograft models. a, b After the tumors reached 50–100 mm3 in size, the mice
received an intraperitoneal administration of LAC117 (100 μg/mL) once daily for 15 days (n = 4, each group). Tumor volume and body weight
were measured every 3 days in HepG2 HCC xenograft mouse models. The average tumor volume in the vehicle- or LAC117-treated group was
plotted. c, d The tumors were isolated from HepG2 xenograft model, and were weighed immediately. Data are expressed as the mean ± SEM
(*P < 0.05 and **P < 0.01)
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LAC117 significantly reduced tumor volume and weight
after 15 days. Moreover, no significant changes in body
weight were observed in animals treated with LAC117
(Fig. 6b), showing that LAC117 was minimally toxic to
mice at the curative dose. In histopathological analysis
by H&E staining, we observed that there was a greater
degree of tumor apoptosis and necrosis in the LAC117-
treated group compared with the control group (Fig. 7).
Also, LAC117 markedly decreased the expression of
PCNA, a cell proliferation marker and increased that of
cleaved caspase-3. In addition, LAC117 decreased the
expression of p-AKT and p- mTOR, downstream of the
PI3K/AKT pathways in tumor tissues. Experimental raw
data were presented in Additional file 1.
Discussion
Natural products have contributed to be most product-
ive source in drug development. They provide the basis
and inspiration for developing effective therapeutics for
human diseases [21, 22]. In cancer, a lot of natural prod-
ucts have currently been used as cancer treatments and
herbal medicines, food supplements, or nutraceuticals
to alleviate toxicity of existing anticancer drugs. In
particular, natural compounds have fundamental capacity
for pharmacological treatments, and more than 50% of all
anti-cancer drugs are derived from natural origins [23].
Recently, a lot of researches have shown that natural
components are useful to prevent and to treat by targeting
essential hallmarks in cancer [24]. Some natural herbal
drugs are also developed to cure HCC [25].
Artemisia capillaris (AC) has been widely used as
alternative therapy to treat various liver diseases including
hepatitis in Asia [26]. In our study, we extracted an
ethanol fraction (LAC117) from the dried leaves of AC
because our preliminary study showed that the leaf extract
had more potent anticancer activity compared to that of
the entire AC plant, and investigated whether LAC117
has anti-cancer effect and its related mechanisms in HCC.
Our study presented that LAC117 reduced cell growth and
induced mitochondria-mediated apoptosis by inhibiting the
PI3K/AKT pathway in vitro and in vivo.
Apoptosis is a physiological process responsible for
cell suicide during development and tissue homeostasis.
Thus, induction of apoptosis is good strategy in
anticancer therapeutics. Also, it is involved in resistance to
chemotherapy, contributing to the negative outcome of
a b
Fig. 7 Effect of LAC117 on the proliferation and apoptosis in HepG2 xenografts. a Tumors were immunostained for PCNA, cleaved caspase-3, p-AKT,
and p-mTOR including H&E staining. b Scheme for how LAC117 induces apoptosis and inhibits the growth of HCC cells. The results were observed by
microscopy at × 400 magnification
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cancer treatments [27]. Upon apoptotic stimuli,
mitochondria-mediated caspases activation triggers apop-
tosis in mammalian cells engage the cell death [28,
29]. In particular, cytochrome c is released from mito-
chondria into the cytosol, where it directly activates cas-
pase caspase-3 activation [30, 31]. In this study, we
observed that LAC117 enhanced the release of cyto-
chrome c from the mitochondria to the cytoplasm, and
increased the expression of cleaved caspase-3 and PARP,
inducing apoptotic cell death. Furthermore, our in vivo
results showed that LAC117 induced apoptosis in tumor
xenograft models and significantly increased expression of
cleaved caspase-3 together with decreased proliferation
(PCNA) in tumor tissues. In previous studies, AC extracts
induced apoptosis by the mitochondrial dysfunction in
breast cancer and leukemia, which was similar to our
findings [32, 33].
Given that LAC117 induced apoptosis in HCC, we
attempted to find a main ingredient that would have
the anticancer effect of LAC117. We detected scopar-
one, chlorogenic acid, hypersin, artepillin, and capillin,
major components of AC using LC-MS, as previously
reported [34]. Unfortunately, main components of
LAC117 did not decrease cell proliferation and not induce
high apoptosis compared with LAC117, extract of AC
leaves in HCC cells (data not shown). Our results show
that various ingredients of LAC117 could synergistically
induce anti-cancer effect of LAC117 in HCC, which is
characteristic of general natural products.
The PI3K/AKT pathway transduces signals from cell
membrane receptors to the cytoplasm, and is closely re-
lated with the proliferation, growth, expansion, and me-
tastasis of tumor cells [35, 36]. Recent researches have
shown that PI3K/AKT pathway is improperly activated in
various human cancers [37]. In particular, p-AKT expres-
sion has been reported to show a positive association with
advanced tumor stage, invasion, and metastatic potential
[38]. Some studies have reported that upregulation of the
PI3K/AKT pathway has shown to be related to a poor
prognosis in HCC and mTOR activation appears to be re-
lated with differentiated tumors and early recurrence after
liver surgery [39, 40]. Therefore, the targeting of PI3K/
AKT pathway may be effective to enhance chemotherapy
in prevention of HCC. Various natural compounds such
as resveratrol, curcumin have shown anti-cancer and
anti-metastatic efficacy by suppression of PI3K/AKT
signaling in HCC [41–43]. Recently, it has shown that
the effect of natural compounds on HCC is not less
than that of approved anti-cancer drugs [25, 44]. Indeed,
Yun et al. have reported that acridine amine, extracted
from sponges (species) effectively inhibited tumor growth
compared with 5-FU by blockade of PI3K/AKT path-
way in HCC [44]. Similar to previous studies, we
found that LAC117 inhibited the activated PI3K/AKT
signaling pathway via the decreases of p-AKT,
p-mTOR, and p-GSK3β in HCC.
Conclusions
Taken together, our results show that LAC117 exhibits
potent anti-cancer activity by inhibiting cell proliferation
and inducing apoptosis via regulation of the PI3K/AKT
pathway in HCC. To the best of our knowledge, our
results are the first to indicate that LAC117 might be a
promising candidate as potentially useful anticancer
drug against HCC.
Additional file
Additional file 1: Raw data from cell viability, cytochrome c releasing
cells, TUNEL positive cells, expression ratio of apoptosis/signaling
molecules, and animal experiments. (XLS 64 kb)
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